| P2093 | author name string | Y Wang | |
| | B Fu | |
| | H-L Hu | |
| | G-X Wang | |
| | Y-A Zhan | |
| P2860 | cites work | PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3 | Q28264650 |
| | Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 |
| | Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis | Q33446102 |
| | Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth | Q33707771 |
| | AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models | Q37301637 |
| | Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 |
| | Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model | Q37398716 |
| | Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. | Q37407113 |
| | Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells | Q39740442 |
| | Recombinant human IFN-beta affects androgen receptor level, neuroendocrine differentiation, cell adhesion, and motility in prostate cancer cells | Q40085697 |
| | Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses | Q40302572 |
| | Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors | Q40748749 |
| | Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells | Q42751429 |
| | Mesenchymal stem cells regulate the proliferation and differentiation of neural stem cells through Notch signaling | Q42834481 |
| | Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study | Q43166168 |
| | Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy | Q45855947 |
| | Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 |
| | Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice | Q45879102 |
| | IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). | Q46703610 |
| | Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 |
| | Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. | Q51822938 |
| | Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 |
| P433 | issue | 1 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| | prostate cancer | Q181257 |
| P304 | page(s) | 317-327 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of International Medical Research | Q15758331 |
| P1476 | title | Mesenchymal stem cells modified to express interferon-β inhibit the growth of prostate cancer in a mouse model | |
| P478 | volume | 40 | |